Wegovy could cause some digestive discomfort like many medications, but these are typically mild and temporary
low levels increase susceptibility to infection Worsened insulin sensitivity the condition GLP-1 drugs are treating can be compounded by vitamin D deficiency, which is independently associated with insulin resistance To understand how to supplement correctly and avoid absorption errors, see our detailed guide on how to actually take vitamin D for maximum absorption
A patient who assumes 1 mg/mL when their vial is 5 mg/mL will draw five times the intended dose
Conversely, adding 1.2 mL instead of 1.0 mL dilutes to 8.33 mg/mL, and every dose is about 17% weaker than planned
Rybelsus, semaglutide-maker Novo Nordisks GLP-1 pill, brute forces its way around this with larger doses, but requires specific dietary instructions and doesnt seem to be as effective for weight loss
While this is the licensed indication, it's important to note that NICE guidance (TA875) recommends more specific criteria for NHS use: typically for people with a BMI 35 kg/m (lower thresholds may apply for some ethnic groups) with at least one weight-related comorbidity, prescribed within specialist weight management services, and limited to a maximum treatment duration of 2 years
